Irina Tudose

Irina Tudose


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
Olguța Anca OrzanOlguța Anca Orzan
Olguța Anca Orzan
ADAlexandra Maria Dorobantu
Alexandra Maria Dorobantu
CGCristian-Dorin Gurău
Cristian-Dorin Gurău
SASibel Ali
Sibel Ali
Mara MihaiMara Mihai
Mara Mihai
Beatrice Bălăceanu-GurăuBeatrice Bălăceanu-Gurău
Beatrice Bălăceanu-Gurău
Dermatofibroma (DF) or fibrous histiocytoma is one of the most frequent benign cutaneous soft-tissue lesions, characterized by a post-inflammatory tissue reaction associated with fibrosis of the dermis. Clinically DFs have a polymorphous clinical aspect from the solitary, firm, single nodules to multiple papules with a relatively smooth surface. However, multiple atypical clinicopathological variants of DFs have been reported and, therefore, clinical recognition may become challenging, leading to a more burdensome identification and sometimes to misdiagnosis. Dermoscopy is considered an important tool in DFs diagnosis, as it improves diagnostic accuracy for clinically amelanotic nodules. Although typical dermoscopic patterns are most frequently seen in clinical practice, there have also been some atypical variants described, mimicking some underlying recurrent and sometimes harmful skin afflictions. Usually, no treatment is required, although an appropriate work-up may be necessary in specific cases, such as in the presence of atypical variants or a history of recent changes. This narrative review’s aim is to summarize current evidence regarding clinical presentation, positive and differential diagnosis of atypical dermatofibromas and also to raise awareness about the importance of specific characteristics of atypical variants to better differentiate them from malignant conditions.

25 March 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
Cristina PopescuCristina Popescu
Cristina Popescu
CMCarmen Andrada Mirea
Carmen Andrada Mirea
ATAndreea Mihaela Truica
Andreea Mihaela Truica
Liliana Gabriela PopaLiliana Gabriela Popa
Liliana Gabriela Popa
APAndrei-Ludovic Porosnicu
Andrei-Ludovic Porosnicu
Marius Nicolae PopescuMarius Nicolae Popescu
Marius Nicolae Popescu
Background: High-frequency ultrasound (HFUS) represents a valuable non-invasive imaging modality for assessing cutaneous tumors. In basal cell carcinoma (BCC), preoperative estimation of tumor depth may support therapeutic decision-making and surgical planning. However, agreement between HFUS-derived and histopathologic depth measurements remains incompletely characterized, particularly with 20 MHz probes in routine clinical practice. Objectives: To evaluate agreement between 20 MHz HFUS and histopathology for BCC tumor depth using Bland–Altman analysis and to derive a preliminary correction equation to estimate histologic depth from HFUS measurements. Methods: This prospective observational pilot study included 15 patients with 16 histologically confirmed BCC lesions. All lesions underwent preoperative 20 MHz HFUS followed by surgical excision, with HFUS-derived tumor depth compared with histopathologic depth. Agreement was assessed using Bland–Altman analysis, and linear regression was performed to derive a preliminary correction equation. Results: Sixteen BCC lesions were analyzed. The mean difference between HFUS and histopathologic tumor depth was −0.07 mm, with 95% limits of agreement from −1.58 to +1.45 mm. HFUS and histopathologic depth measurements were highly correlated (R2 = 0.99). A correction equation was derived: estimated histopathologic depth (mm) = −0.52 + 1.10 × HFUS depth (mm). Conclusions: Twenty MHz HFUS demonstrated good agreement with histopathology for tumor depth assessment in BCC, with clinically acceptable variability. The proposed correction equation may improve interpretation of HFUS measurements; however, further validation in larger cohorts is required.

9 March 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
Olguța Anca OrzanOlguța Anca Orzan
Olguța Anca Orzan
Cǎlin GiurcǎneanuCǎlin Giurcǎneanu
Cǎlin Giurcǎneanu
BDBogdan Dima
Bogdan Dima
MDMonica Beatrice Dima
Monica Beatrice Dima
AIAna Ion
Ana Ion
ADAlexandra Maria Dorobantu
Alexandra Maria Dorobantu
The occurrence of both melanoma and glioma was first suggested by the observation of a familial association between these conditions, which was later confirmed by the description of the melanoma–astrocytoma syndrome, an extremely rare, inherited affliction in which people have an increased risk of developing melanoma and nervous system tumors. Taking into consideration the common embryologic precursor, the neuroectoderm, it was hypothesized that this syndrome is associated with a genetic disorder. While some families with germline CDKN2A mutations are prone to develop just melanomas, others develop both melanomas and astrocytomas or even other nervous-system neoplasms. Herein, we report the case of a 63-year-old male patient with no personal or family history of malignancy who had primary melanoma followed by glioblastoma. Our case report suggests that the occurrence of both melanoma and glioblastoma is most likely not coincidental but instead linked to genetic mutations of common embryologic precursors or signaling pathways.

14 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ACAdriana Nicoleta Cristescu
Adriana Nicoleta Cristescu
IDIoana Dumitrescu
Ioana Dumitrescu
ITIrina Tudose
Irina Tudose
Cristina PopescuCristina Popescu
Cristina Popescu
ADAna-Maria Dumitrescu
Ana-Maria Dumitrescu
Liliana Gabriela PopaLiliana Gabriela Popa
Liliana Gabriela Popa
Cutaneous angiosarcoma is a rare and aggressive malignant tumor that originates from the endothelial cells of blood vessels or lymphatic vessels. More than half of cutaneous angiosarcoma cases occur in the head and neck regions, particularly on the scalp. However, due to its rarity, scalp angiosarcoma is often overlooked in clinical practice. The lack of distinctive symptoms usually delays the diagnosis and, implicitly, the initiation of appropriate treatment. The treatment of cutaneous angiosarcoma poses great challenges due to its multifocal occurrence and the frequent extensive microscopic spread. A personalized, multimodal therapeutic approach is essential for ensuring a favorable outcome, consisting of a wide surgical excision associated with adjuvant radiotherapy in localized tumors, concurrent adjuvant radiotherapy and chemotherapy, targeted treatments, or immunotherapy in advanced or metastatic diseases. The aim of this manuscript is to review the literature data regarding the individualized management of cutaneous angiosarcoma and to share our own experiences in the field. We wish to underscore the importance of considering cutaneous angiosarcoma in the differential diagnosis of scalp tumors, especially in patients with a history of scalp irradiation as early detection, accurate diagnosis, and a multidisciplinary, personalized management, including surgery with clear margins and adjuvant radiation therapy, are crucial for ensuring a favorable outcome.

1 November 2024 in Medicina
Verified
Journal Article
Open access
PDF file
CMCarmen Andrada Mirea
Carmen Andrada Mirea
Cristina PopescuCristina Popescu
Cristina Popescu
ARAndreea Racoviță
Andreea Racoviță
COCristina-Mihaela Olaru
Cristina-Mihaela Olaru
ITIrina Tudose
Irina Tudose
Liliana Gabriela PopaLiliana Gabriela Popa
Liliana Gabriela Popa
Cutaneous metastases from clear cell renal carcinoma (ccRC) are uncommon and often indicate a poor prognosis. These metastases typically occur on the scalp, face, and trunk, and they can be difficult to diagnose due to their resemblance to benign dermatological tumors. We report the case of a 56-year-old patient with a history of ccRC (TNM stage 4) who was referred to our dermatology department with two rapidly enlarging, painful lesions on the left jawline and scalp, which had developed one month and one week earlier, respectively. On examination, the lesions appeared as well-defined, round to oval plaques with a central ulceration and a peripheral red rim, suggestive of an inflammatory appearance. Dermoscopic examination revealed a structureless pink to orange pattern, atypical central vessels, and irregular linear vessels in a corona-like arrangement. Despite the patient’s stable oncological treatment for six months, pain management had recently included paracetamol, tramadol, and NSAIDs. The primary presumptive diagnosis was of cutaneous metastasis, considering the patient’s history of metastatic ccRC. However, given the recent initiation of new pharmacological agents, the rapid progression of the cutaneous lesions, and their clinical presentation, alternative differential diagnoses were considered, including drug-induced reactions such as erythema multiforme or fixed drug eruption. A biopsy of the facial lesion revealed immunohistochemical positivity for CD10, CAIX, and PAX8, confirming the diagnosis of metastatic ccRC with sarcomatoid differentiation. Unfortunately, despite continued targeted therapies and palliative care, the patient’s condition deteriorated rapidly, leading to death two months later. This case highlights the potential for extremely rapidly evolving cutaneous metastases from ccRC and their capacity to occasionally mimic atypical drug eruptions. Additionally, it reaffirms the poor prognosis of such metastases, as evidenced by the patient’s death within two months.

4 July 2024 in Dermato
Verified
Journal Article
Open access
PDF file
ADAlexandra Maria Dorobantu
Alexandra Maria Dorobantu
Mihai LupuMihai Lupu
Mihai Lupu
Liliana Gabriela PopaLiliana Gabriela Popa
Liliana Gabriela Popa
RTRaluca Tatar
Raluca Tatar
Cǎlin GiurcǎneanuCǎlin Giurcǎneanu
Cǎlin Giurcǎneanu
Olguța Anca OrzanOlguța Anca Orzan
Olguța Anca Orzan
Actinomycosis, an uncommon granulomatous infection caused by the Actinomyces species, rarely targets as primary involvement the limb and is often linked to traumatic incidents. In this report, we present the case of a 44-year-old female who developed multiple small nodules on her left foot over approximately 12 months. Some nodules exhibited firmness and a violet hue, while others discharged a yellowish fluid. The patient had no significant comorbidities. Despite thorough blood paraclinical assessments, including complete blood count, serological HIV testing, and QuantiFERON-TB Gold testing, no abnormalities were detected. Bacteriological examinations and cultures of the discharge yielded negative results. Dermatoscopic examination revealed ovoid yellowish structures, with confocal microscopy highlighting granulomas. A subsequent skin biopsy confirmed characteristic changes indicative of actinomycosis. Although systemic antibiotic therapy with penicillin derivatives was initially considered, the patient’s documented allergic history to this medication class, verified through allergological testing, prompted the initiation of doxycycline treatment. Notably, significant improvement was observed at the 3-month follow-up. This case underscores the importance of reporting rare instances of actinomycosis due to its diagnostic complexity and management challenges.